|
|
Oramed Pharmaceuticals Inc
TLV •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTLV
Market Capitalization484.56 mln
Float28.57 mln
Earnings Date08/14/2026
P / E
1.61
Deeply undervalued
Key Fundamentals
EPS7.35
P/E1.61
ROE58.72
ROIC-12.71
ROA53.43
EBITDA, mln221
EV / EBITDA1.25
EV / EBIT1.25
EV / Revenue49.11
Financial Strength
Piotroski F-Score
2
/ 9
Price to Intrinsic Value4.07
Price to Graham Number0.28
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
1.74% |
74
/ 100
 |
| 1 Month |
-15.76% |
11
/ 100
 |
| 2 Months |
3.25% |
61
/ 100
 |
| 6 Months |
35.99% |
86
/ 100
 |
| 1 Year |
57.65% |
79
/ 100
 |
|
| |
